HARROW, INC.

HROW · Nasdaq · SIC 2834: Pharmaceutical Preparations
384
SEC Filings

Business Summary

PART I Overview We are a leading provider of ophthalmic disease management solutions in North America, and were founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For over a decade, we have partnered with U.S. eyecare professionals to develop a comprehensive portfolio of high-quality products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye di...

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionHROWdiscussed_in_filing Artificial Intelligence
topic_mentionHROWdiscussed_in_filing Cybersecurity
topic_mentionHROWdiscussed_in_filing Trusted Computing
topic_mentionHROWdiscussed_in_filing Blockchain & Crypto
topic_mentionHROWdiscussed_in_filing Supply Chain
topic_mentionHROWdiscussed_in_filing Regulation
topic_mentionHROWdiscussed_in_filing Automotive
topic_mentionHROWdiscussed_in_filing Healthcare & Bio
topic_mentionHROWdiscussed_in_filing Sovereign & Government
topic_mentionHROWdiscussed_in_filing Artificial Intelligence
topic_mentionHROWdiscussed_in_filing Cybersecurity
topic_mentionHROWdiscussed_in_filing Trusted Computing
topic_mentionHROWdiscussed_in_filing Blockchain & Crypto
topic_mentionHROWdiscussed_in_filing Supply Chain
topic_mentionHROWdiscussed_in_filing Regulation
topic_mentionHROWdiscussed_in_filing Automotive
topic_mentionHROWdiscussed_in_filing Healthcare & Bio
topic_mentionHROWdiscussed_in_filing Sovereign & Government
topic_mentionHROWdiscussed_in_filing Artificial Intelligence
topic_mentionHROWdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001493152-26-008562EDGAR77K words
2025-03-272024-12-310001641172-25-000925EDGAR
2024-03-192023-12-310001493152-24-010518EDGAR
2023-03-232022-12-310001493152-23-008718EDGAR
2022-03-102021-12-310001493152-22-006525EDGAR
2021-03-082020-12-310001493152-21-005583EDGAR
2020-03-132019-12-310001493152-20-003862EDGAR
2019-03-122018-12-310001493152-19-003188EDGAR
2018-03-082017-12-310001493152-18-003095EDGAR
2017-03-212016-12-310001493152-17-002687EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001493152-25-021562EDGAR32K words
2025-08-112025-06-300001641172-25-022980EDGAR
2025-05-082025-03-310001641172-25-009263EDGAR
2024-11-142024-09-300001493152-24-045295EDGAR
2024-08-072024-06-300001493152-24-030575EDGAR
2024-05-132024-03-310001493152-24-018902EDGAR
2023-11-132023-09-300001493152-23-040563EDGAR
2023-08-092023-06-300001493152-23-027361EDGAR
2023-05-112023-03-310001493152-23-016414EDGAR
2022-11-142022-09-300001493152-22-032076EDGAR
2022-08-092022-06-300001493152-22-021769EDGAR
2022-05-052022-03-310001493152-22-012261EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001493152-26-013199EDGAR18K words
2026-03-240001493152-26-012389EDGAR
2026-03-240001493152-26-012279EDGAR
2026-03-100001493152-26-009452EDGAR
2026-03-020001493152-26-008552EDGAR
2026-02-020001493152-26-004635EDGAR
2025-11-180001493152-25-023988EDGAR
2025-11-100001493152-25-021555EDGAR
2025-10-060001493152-25-017007EDGAR
2025-09-290001493152-25-015878EDGAR

384 total filings indexed. 352 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001360214
TickerHROW
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6e9e4614178b02c888a0113fe7dfac71682768d72f4ce0894e3207b801aefab4
parent: 2a92bbe8294c883dc88c12cdfa326a5dc483fc779640949e72f349a58e6bd1c8
content hash: d95955a1897f20c6751caa1a8f80e9980934bf881ba46a274737889e94140617
signed: 2026-04-13T04:45:32.796Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf